The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial (Q35576155)

8 August 2017

The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial (English)

1 reference

8 August 2017

Jürgen Floege

1

1 reference

8 August 2017

Yumi Kubo

2

1 reference

8 August 2017

Anna Floege

3

1 reference

8 August 2017

Glenn M Chertow

4

1 reference

8 August 2017

Patrick S Parfrey

5

1 reference

8 August 2017

17 April 2015

1 reference

Clinical Journal of the American Society of Nephrology

8 August 2017

1 reference

8 August 2017

10

1 reference

8 August 2017

800-807

1 reference

8 August 2017

5

1 reference

Calcific uraemic arteriolopathy: a rare disease with a potentially high impact on chronic kidney disease-mineral and bone disorder

8 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4422249

Vitamin K antagonists: beyond bleeding

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4422249

Statin use and calcific uremic arteriolopathy: a matched case-control study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4422249

Calciphylaxis: a still unmet challenge

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4422249

Calciphylaxis from Nonuremic Causes: A Systematic Review

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4422249

Calciphylaxis: calcific uremic arteriolopathy and the emerging role of sodium thiosulfate

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4422249

Calciphylaxis: natural history, risk factor analysis, and outcome

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4422249

Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4422249

Calcific uremic arteriolopathy in association with low turnover uremic bone disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4422249

Calciphylaxis in patients on hemodialysis: a prevalence study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4422249

Calciphylaxis and subtotal parathyroidectomy: a double-edged sword.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4422249

The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4422249

Novel insights into osteogenesis and matrix remodelling associated with calcific uraemic arteriolopathy

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4422249

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4422249

Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4422249

A case-control study of calciphylaxis in Japanese end-stage renal disease patients

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4422249

Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4422249

A strategy for the treatment of calcific uremic arteriolopathy (calciphylaxis) employing a combination of therapies

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4422249

Cutaneous necrosis from calcific uremic arteriolopathy

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25887067

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Risk factors and mortality associated with calciphylaxis in end-stage renal disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25887067

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Calciphylaxis is usually non-ulcerating: Risk factors, outcome and therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25887067

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2215/CJN.10221014

1 reference

8 August 2017

1 reference

8 August 2017

1 reference